NASDAQ:MNKD - MannKind Corporation
$1.41
 $0.02
+1.33%
2:50PM EDT
2019-02-15
MannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control. AFREZZA consists of a dry formulation of human insulin delivered from a portable inhaler. AFREZZA utilizes its Technosphere formulation technology. Technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics. Technosphere powders are based on the Company's fumaryl diketopiperazine (FDKP), which is a potential of Hydrogen (pH)-sensitive organic molecule that self-assembles into small particles under acidic conditions. The Company has also created a range of breath-powered, dry powder inhalers. Its inhalers can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MNKD     avg for
industry  
  avg for
sector  
42 stocks weight:  16. 74   0. 00   0. 00  
42 stocks rank:  3. 76 K 1. 86 K 1. 09 K
# analyst opinions:  1. 00   14. 92   14. 43  

quick ratio:  0. 22   5. 37   1. 81  
current ratio:  0. 33   5. 69   2. 19  

target price low:  4. 00   88. 97   117. 82  
target price avg:  4. 00   115. 19   141. 96  
target price high:  4. 00   143. 40   163. 16  
1-yr high:  3. 27   124. 30   142. 77  
last close:  1. 39   101. 85   127. 84  
50-day avg:  1. 37   98. 27   122. 46  
200-day avg:  1. 63   99. 72   122. 70  
1-yr low:  1. 01   78. 19   100. 16  
volume:  2. 45 M 2. 38 M 4. 64 M
50-day avg volume:  2. 42 M 3. 31 M 4. 94 M
200-day avg volume:  3. 08 M 3. 23 M 4. 28 M

1-day return:  -3. 47 % 0. 22 % 0. 48 %
this week return:  6. 92 % 1. 77 % 2. 01 %
12-wk return:  -21. 02 % 6. 56 % 3. 33 %
52-wk return:  -50. 85 % -2. 23 % 14. 35 %

enterprise value (EV):  326. 45 M 55. 17 B 104. 51 B
market cap:  258. 91 M 49. 01 B 96. 46 B
EBITDA:  -97. 77 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -3. 34   -91. 79   2. 29  
enterprise/revenue (EV/R):  20. 72   29. 84   23. 39  
total revenue:  15. 76 M 11. 28 B 40. 22 B
total debt:  105. 48 M 13. 73 B 16. 57 B
net income (common):  -110. 01 M 2. 37 B 3. 58 B

shares outstanding:  186. 26 M 607. 99 M 1. 22 B
shares:  137. 77 M 605. 53 M 1. 15 B
shares short:  38. 81 M 11. 62 M 12. 55 M
shares short prior month:  39. 44 M 11. 95 M 13. 44 M
short ratio:  16. 34   4. 82   3. 10  
short % of float:  31. 85 % 6. 19 % 2. 82 %
total cash/share:  0. 07   12. 02   11. 46  
total cash:  10. 45 M 7. 41 B 7. 37 B
free cash flow:  -47. 79 M 95. 99 M 2. 04 B
operating cash flow:  -92. 70 M 164. 74 M 3. 04 B

book value:  -1. 29   14. 43   28. 26  
price/book:  -1. 08   -1. 57   -2. 97  
gross profits:  -6. 08 M 8. 28 B 18. 09 B
operating margins:  -633. 65 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  -23. 27 % 49. 33 % 54. 53 %

1-yr max volatility:  89. 09 % --- ---
1-yr mean volatility:  -0. 10 % 0. 01 % 0. 06 %

1-yr EPS:  -0. 83   3. 03   4. 09  
forward EPS:  -0. 62   4. 33   6. 99  
P/E:  -1. 67   6. 11   26. 91  
forward P/E:  -2. 24   8. 38   10. 48  
PE/G:  -0. 01   0. 37   5. 61  
growth:  118. 70 % 683. 72 % 104. 79 %
earnings high:  -0. 17   1. 27   1. 66  
earnings avg:  -0. 17   1. 01   1. 53  
earnings low:  -0. 17   0. 76   1. 40  
revenue high:  5. 69 M 2. 86 B 11. 19 B
revenue avg:  5. 20 M 2. 78 B 10. 84 B
revenue low:  4. 70 M 2. 67 B 10. 64 B
return on assets:  -122. 55 % -3. 27 % 3. 81 %
revenue growth:  118. 70 % 648. 36 % 97. 70 %
revenue/share:  0. 12   14. 68   59. 83  

beta (1yr vs S&P500):  1. 04   1. 21   0. 93  
sharpe (1yr):  -0. 21   0. 06   0. 98  

held % insiders:  7. 36 % 6. 46 % 3. 21 %
held % institutions:  30. 83 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : MNKD
.    + 0.348 =         0.348 :: INITIAL WEIGHT
.  + 256.556 =       256.904 :: inverse volume-to-price addition
.   + 499.43 =       756.334 :: spline projection addition
.  - 167.681 =       588.653 :: poor performance penalty
.    x 0.666 =       392.293 :: one-year gains+dividend factor
.     x 6.54 =      2565.675 :: 13 weeks' performance factor
.    x 1.492 =      3829.242 :: industry recommendation factor
.    x 1.694 =      6488.256 :: EV/R factor
.    x 0.988 =      6408.741 :: return on assets factor
.      x 2.3 =     14737.387 :: revenue growth factor
.    x 2.057 =      30321.19 :: current ratio factor
.     x 1.46 =     44283.509 :: quick ratio factor
.     x 1.03 =     45618.453 :: short ratio factor
.    x 1.989 =     90744.594 :: price-to-book factor
.    x 1.009 =     91526.076 :: 5-day avg > 50-day avg
.    x 2.167 =    198305.093 :: P/E weight
.    x 2.209 =    438047.843 :: PE/G factor
.    x 1.798 =    787678.509 :: beta factor
.    x 0.213 =    167565.425 :: sharpe factor
.    x 2.611 =    437480.727 :: target low factor
.    x 1.457 =     637306.05 :: target mean factor
.    x 1.137 =    724635.534 :: target high factor
.    x 1.066 =    772180.905 :: industry 12-weeks return
.    x 0.941 =    726767.861 :: "drift" penalty 3 days ago
.    x 0.934 =    678702.065 :: "drift" penalty 5 days ago
.    x 0.999 =    678336.336 :: overall "drift" factor
.    x 0.109 =     74000.402 :: largest single-day jump factor
.    x 0.063 =      4686.536 :: low price factor
.      x 1.0 =      4686.851 :: factor hist industry gain for week 06
.   cubeRoot =        16.735 :: reduced for readability
.                     16.735 :: FINAL WEIGHT for NASDAQ:MNKD


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org